Pfizer’s vaccine against respiratory syncytial virus, a common disease that injures and kills thousands of seniors annually, was approved by the Food and Drug Administration on Wednesday. In a statement released on Wednesday, Pfizer stated that it anticipates having supplies available prior to the RSV season in the third quarter of this year. On June…
The US Department of Health and Human Services said on Wednesday that the Biden administration has agreed to buy 105 million doses of Pfizer’s Covid-19 vaccine. The contract, which is for vaccinations in the fall, totals $3.2 billion and includes “options for up to 300 million doses,” according to an agency news release. The order,…
On Monday, Pfizer CEO Albert Bourla indicated that two doses of the company’s vaccine may not provide adequate protection against infection by the omicron Covid form, and that the initial shots have lost part of their efficacy in avoiding hospitalisation. Bourla stressed the importance of a third shot to increase people’s protection against omicron in…
Paxlovid, a COVID-19-fighting antiviral oral medication developed by Pfizer, received emergency approval from the Health Ministry on Sunday. Israel has negotiated a deal with Pfizer for the medicine, according to the government, and a shipment is anticipated to arrive in the coming days. The US Food and Drug Administration (FDA) granted emergency approval for the…
According to Pfizer officials, Covid will become an endemic disease as early as 2024, meaning the virus would convert from a worldwide emergency to a persistent presence causing regional outbreaks around the world, similar to the flu. During a Friday investor call, Nanette Cocero, worldwide head of Pfizer Vaccines, said, “We believe Covid will transition…
President Joe Biden announced on Thursday that the United States has purchased 10 million courses of Pfizer’s Covid treatment tablet, an oral antiviral medicine that was shown in a clinical trial to be very successful in reducing hospitalisation among high-risk patients. Paxlovid, the tablet, has the potential to revolutionise the fight against the virus by…
Pfizer and BioNTech’s Covid-19 vaccine is safe and generates a “robust” immune response in a clinical trial of children ages 5 to 11, the drugmakers reported in a press release Monday. The organizations tested a two-dose regimen of 10 micrograms — about a third the dosage utilized for teens and adults — directed three weeks…